Support for psychiatric clinics to increase prescribing of medicines for alcohol use disorder
External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting
This project will test whether providing outside facilitation, training, and clinic-level supports in three psychiatric clinics helps clinicians prescribe medications for people with major mental illness who also have alcohol use disorder.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | University of Maryland, Baltimore Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Trial ID | NCT07053098 on ClinicalTrials.gov |
What this trial studies
This pilot uses an external facilitator working with internal clinic champions at three psychiatric clinics to increase prescribing of medications for alcohol use disorder (MAUD) for patients with major mental illness and AUD. The intervention includes clinic-level education, standardized screening with electronic health record documentation, weekly audit-and-feedback and care coordination, access to MAUD clinician consultation, and on-site patient educational materials. Activities occur across pre-implementation, implementation, and a post-implementation sustainment period with formative evaluation throughout. The work is guided by the integrated Promoting Action on Research Implementation in Health Services (i-PARIHS) framework.
Who should consider this trial
Good fit: Ideal participants are adults with a major mental illness who also have alcohol use disorder and receive care at one of the participating psychiatric clinics, along with clinic staff (prescribers, non-prescribing clinicians, or administrators) who will engage in the implementation activities.
Not a fit: Patients under 18, those unable to complete informed consent, or individuals treated outside the participating clinics are not eligible and will not directly benefit from this intervention.
Why it matters
Potential benefit: If successful, more patients with major mental illness and alcohol use disorder could receive evidence-based medications for AUD, which may reduce heavy drinking and related harms.
How similar studies have performed: Some prior implementation efforts have increased MAUD uptake in general medical settings, but applying external facilitation specifically within psychiatric clinics is a more novel approach with limited prior evidence in this population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * For prescribers: working as a prescriber, non-prescribing clinician, or administrator at one of the three participating clinics. * For patients: has major mental illness (major depressive disorders, bipolar disorder, schizophrenia spectrum disorders, other psychotic disorders; posttraumatic stress disorder) * For patients: has Alcohol Use Disorder and is being treated in one of the three participating clinics. Exclusion Criteria: * For all: age is less than 18 years old * For all: not able to complete informed consent
Where this trial is running
Baltimore, Maryland
- University of Maryland Baltimore — Baltimore, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: Melanie Bennett — University of Maryland, Baltimore
- Study coordinator: Melanie Bennett, PhD
- Email: mbennett@som.umaryland.edu
- Phone: 410-706-2490
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.